What it means
A UK medicine’s licence specifies the uses and circumstances assessed by the regulator. Using it outside those terms—for example for another condition, age group, dose or route—is called off-label use. That is different from using a product that has no applicable UK licence.
In context
Off-label prescribing can be appropriate when a prescriber judges it justified by evidence and the person’s needs. It carries responsibilities for explaining treatment, monitoring and follow-up. Off-label does not mean proven ineffective, automatically recommended or regulator-approved for that use. NICE recommendations and local funding decisions are separate questions from the product licence.
Sources and References
- Off-label or unlicensed use of medicines: prescribers’ responsibilities
Scope: United Kingdom.
Article Information
- Edition
- United Kingdom
- Content updated
- 2026-10-17
- Sources checked
- Listed with each reference above; retained dates for shared scientific content.
- Publication status
- Published
- Scope
- UK terminology and clinical context; a glossary definition, not a diagnostic or prescribing tool.

